272 related articles for article (PubMed ID: 19397838)
21. Role of growth factors in diabetic kidney disease.
Chiarelli F; Gaspari S; Marcovecchio ML
Horm Metab Res; 2009 Aug; 41(8):585-93. PubMed ID: 19452424
[TBL] [Abstract][Full Text] [Related]
22. Diabetic nephropathy: important pathophysiologic mechanisms.
Soldatos G; Cooper ME
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S75-9. PubMed ID: 18994672
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and the pathogenesis of diabetic nephropathy.
Wada J; Makino H
Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333
[TBL] [Abstract][Full Text] [Related]
24. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.
Nair S; Phillips AO; Norton N; Spurlock G; Williams HJ; Craig KJ; Williams JD; Williams NM; Bowen T
J Nephrol; 2008; 21(3):400-5. PubMed ID: 18587729
[TBL] [Abstract][Full Text] [Related]
25. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
[TBL] [Abstract][Full Text] [Related]
26. Nephropathy in type 1 diabetes.
Marre M
Semin Vasc Med; 2002 Feb; 2(1):97-107. PubMed ID: 16222600
[TBL] [Abstract][Full Text] [Related]
27. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy.
Moczulski DK; Fojcik H; Wielgorecki A; Trautsolt W; Gawlik B; Kosiorz-Gorczynska S; Oczko-Wojciechowska M; Wiench M; Strojek K; Zukowska-Szczechowska E; Grzeszczak W
Diabet Med; 2007 Mar; 24(3):266-71. PubMed ID: 17263765
[TBL] [Abstract][Full Text] [Related]
28. Role of the USF1 transcription factor in diabetic kidney disease.
Sanchez AP; Zhao J; You Y; Declèves AE; Diamond-Stanic M; Sharma K
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F271-9. PubMed ID: 21543418
[TBL] [Abstract][Full Text] [Related]
29. [Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy].
Benito-Martín A; Ucero AC; Santamaría B; Lorz C; Kretzler M; Rastaldi MP; Sánchez-Niño MD; Sanz A; Izquierdo MC; Ruiz Ortega M; Egido J; Ortiz A
Nefrologia; 2009; 29(1):13-9. PubMed ID: 19240767
[TBL] [Abstract][Full Text] [Related]
30. Genetics of diabetic nephropathy: lessons from mice.
Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
[TBL] [Abstract][Full Text] [Related]
31. [Current questions concerning the pathomechanism of diabetic nephropathy].
Mogyorósi A; de Châtel R; Ziyadeh FN
Orv Hetil; 1996 Dec; 137(51):2845-50. PubMed ID: 9679619
[TBL] [Abstract][Full Text] [Related]
32. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy.
Ha H; Hwang IA; Park JH; Lee HB
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S42-5. PubMed ID: 18845352
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in diabetic nephropathy.
Zent R; Pozzi A
Semin Nephrol; 2007 Mar; 27(2):161-71. PubMed ID: 17418685
[TBL] [Abstract][Full Text] [Related]
34. Control of mammalian gene expression by amino acids, especially glutamine.
Brasse-Lagnel C; Lavoinne A; Husson A
FEBS J; 2009 Apr; 276(7):1826-44. PubMed ID: 19250320
[TBL] [Abstract][Full Text] [Related]
35. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
[TBL] [Abstract][Full Text] [Related]
37. Comparative proteome analysis of TGF-beta1-induced fibrosis processes in normal rat kidney interstitial fibroblast cells in response to ascofuranone.
Kang JH; Cho HJ; Lee IS; Kim M; Lee IK; Chang YC
Proteomics; 2009 Oct; 9(19):4445-56. PubMed ID: 19688726
[TBL] [Abstract][Full Text] [Related]
38. Connective tissue growth factor, matrix regulation, and diabetic kidney disease.
McLennan SV; Abdollahi M; Twigg SM
Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):85-92. PubMed ID: 23197157
[TBL] [Abstract][Full Text] [Related]
39. The role of inflammatory cytokines in diabetic nephropathy.
Navarro-González JF; Mora-Fernández C
J Am Soc Nephrol; 2008 Mar; 19(3):433-42. PubMed ID: 18256353
[TBL] [Abstract][Full Text] [Related]
40. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
